Collectively, the inflammatory stress, the decrease in miR-122 and associated hyperinsulinemia in NASH presents a reasonable explanation for the constant activation of SREBP2 bypassing the canonical negative feedback inhibitory effect of high levels of cellular cholesterol (37). Here, SREBF2 is linked to metabolic dysfunction-associated steatohepatitis.